Fu-Hua Peng

623 total citations
27 papers, 351 citations indexed

About

Fu-Hua Peng is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Fu-Hua Peng has authored 27 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 16 papers in Cardiology and Cardiovascular Medicine and 7 papers in Internal Medicine. Recurrent topics in Fu-Hua Peng's work include Pulmonary Hypertension Research and Treatments (17 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Vascular Anomalies and Treatments (5 papers). Fu-Hua Peng is often cited by papers focused on Pulmonary Hypertension Research and Treatments (17 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Vascular Anomalies and Treatments (5 papers). Fu-Hua Peng collaborates with scholars based in China, United States and United Kingdom. Fu-Hua Peng's co-authors include Zhi‐Cheng Jing, Xin Jiang, Rong Jiang, Xi-Qi Xu, Yan Wu, Kai Sun, Qin‐Hua Zhao, Wenhui Wu, Tian‐Yu Lian and Yuanqiang Zhang and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Respiratory and Critical Care Medicine and The American Journal of Cardiology.

In The Last Decade

Fu-Hua Peng

22 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fu-Hua Peng China	10	251	141	63	35	34	27	351
Rika Suda Japan	12	266 1.1×	135 1.0×	102 1.6×	28 0.8×	54 1.6×	39	372
Xi‐Qi Xu China	9	310 1.2×	178 1.3×	48 0.8×	32 0.9×	86 2.5×	24	362
Thomas Koudstaal Netherlands	13	292 1.2×	77 0.5×	87 1.4×	24 0.7×	20 0.6×	20	384
Katsuya Kozu Japan	9	263 1.0×	198 1.4×	58 0.9×	23 0.7×	67 2.0×	16	350
Zhi-Yan Han China	7	250 1.0×	148 1.0×	38 0.6×	26 0.7×	71 2.1×	10	297
Aaron W. Trammell United States	8	360 1.4×	202 1.4×	76 1.2×	32 0.9×	31 0.9×	21	417
Ryotaro Asano Japan	9	176 0.7×	137 1.0×	26 0.4×	13 0.4×	28 0.8×	38	262
Isabelle Ding Germany	5	183 0.7×	169 1.2×	72 1.1×	35 1.0×	20 0.6×	6	339
Melanie Nies United States	11	288 1.1×	131 0.9×	53 0.8×	82 2.3×	38 1.1×	29	364
Laura West United Kingdom	5	68 0.3×	100 0.7×	46 0.7×	26 0.7×	16 0.5×	7	234

Countries citing papers authored by Fu-Hua Peng

Since Specialization

Citations

This map shows the geographic impact of Fu-Hua Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu-Hua Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu-Hua Peng more than expected).

Fields of papers citing papers by Fu-Hua Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fu-Hua Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu-Hua Peng. The network helps show where Fu-Hua Peng may publish in the future.

Co-authorship network of co-authors of Fu-Hua Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Fu-Hua Peng. A scholar is included among the top collaborators of Fu-Hua Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fu-Hua Peng. Fu-Hua Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Hui, et al.. (2025). Epibrassinolide Regulates Lhcb5 Expression Though the Transcription Factor of MYBR17 in Maize. Biomolecules. 15(1). 94–94.

Xia, Yinhang, Peng Gao, Jusheng Gao, et al.. (2025). Covering green manure increases rice yields via improving nitrogen cycling between soil and crops in paddy fields. Agriculture Ecosystems & Environment. 383. 109517–109517. 9 indexed citations

Zhang, Hongda, et al.. (2024). Semaglutide for the prevention of atrial fibrillation: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 18(6). 103067–103067. 11 indexed citations

Zhang, Hongda, Lijie Mi, Fu-Hua Peng, et al.. (2024). Joint effect of atrial fibrillation and obesity on mortality in critically ill patients. Diabetology & Metabolic Syndrome. 16(1). 169–169.

Yan, Xinxin, et al.. (2023). Prognostic significance of quantitative electrocardiographic parameters in patients with non-high-risk pulmonary embolism. European Journal of Internal Medicine. 120. 46–51. 4 indexed citations

Tong, Jiayi, Chongliang Luo, Huiqin Liu, et al.. (2022). Predictors of Lung Adenocarcinoma With Leptomeningeal Metastases: A 2022 Targeted-Therapy-Assisted molGPA Model. Frontiers in Oncology. 12. 903851–903851.

Wu, Yan, Song Hu, Xinxin Yan, et al.. (2022). Chronic Thromboembolic Pulmonary Hypertension in Females: Clinical Features and Survival. Journal of Cardiovascular Development and Disease. 9(9). 308–308. 1 indexed citations

Lian, Tian‐Yu, Jianzhou Liu, Yu‐Ping Zhou, et al.. (2022). Prevalence, Genetic Background, and Clinical Phenotype of Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension. JACC Asia. 2(3). 247–255. 2 indexed citations

Tan, Jiang‐Shan, Ningning Liu, Yan Wu, et al.. (2022). Association Between the Use of Pre- and Post-thrombolysis Anticoagulation With All-Cause Mortality and Major Bleeding in Patients With Pulmonary Embolism. Frontiers in Cardiovascular Medicine. 9. 880189–880189. 1 indexed citations

10.

Zhou, Yu‐Ping, Yunpeng Wei, Xi‐Qi Xu, et al.. (2022). Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension. Journal of the American College of Cardiology. 79(15). 1477–1488. 10 indexed citations

11.

Wu, Yan, Fu-Hua Peng, Xinxin Yan, et al.. (2022). Safety of chronic high-dose calcium channel blockers exposure in children with pulmonary arterial hypertension. Frontiers in Cardiovascular Medicine. 9. 918735–918735.

12.

Zhang, Hongda, Yi Yan, Yangyang He, et al.. (2022). Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease. International Journal of Cardiology. 375. 29–35. 3 indexed citations

13.

Hu, Song, Jiang‐Shan Tan, Sheng Liu, et al.. (2021). The long-term survival in patients with chronic thromboembolic pulmonary hypertension: experience from a single center in China. Journal of Thrombosis and Thrombolysis. 53(4). 926–933. 3 indexed citations

14.

Hu, Song, Jiang‐Shan Tan, Sheng Liu, et al.. (2021). Development and Validation of a Nomogram for Predicting the Long-Term Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension. The American Journal of Cardiology. 163. 109–116. 2 indexed citations

15.

He, Yangyang, Yi Yan, Xin Jiang, et al.. (2020). Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension. European Respiratory Journal. 56(5). 2000522–2000522. 47 indexed citations

16.

Wang, Xiaojian, Tian‐Yu Lian, Xin Jiang, et al.. (2018). GermlineBMP9mutation causes idiopathic pulmonary arterial hypertension. European Respiratory Journal. 53(3). 1801609–1801609. 90 indexed citations

17.

Xu, Xi-Qi, Qianqian Liu, Qin‐Hua Zhao, et al.. (2016). Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension. International Journal of Cardiology. 228. 895–899. 27 indexed citations

18.

Jiang, Xin, Yuefu Wang, Qin‐Hua Zhao, et al.. (2014). Acute hemodynamic response of infused fasudil in patients with pulmonary arterial hypertension: A randomized, controlled, crossover study. International Journal of Cardiology. 177(1). 61–65. 32 indexed citations

19.

Wu, Wenhui, Lu Yang, Fu-Hua Peng, et al.. (2012). Lower Socioeconomic Status Is Associated with Worse Outcomes in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 187(3). 303–310. 47 indexed citations

20.

Zhao, Qin‐Hua, Fu-Hua Peng, Hong Wei, et al.. (2012). Serum High-Density Lipoprotein Cholesterol Levels as a Prognostic Indicator in Patients With Idiopathic Pulmonary Arterial Hypertension. The American Journal of Cardiology. 110(3). 433–439. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact